메뉴 건너뛰기




Volumn 49, Issue 1, 1996, Pages 81-82

Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: Part 1. The results against Pseudomonas aeruginosa

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFPIROME; GENTAMICIN; IMIPENEM; PIPERACILLIN; TOBRAMYCIN;

EID: 29044441274     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (23)
  • 1
    • 0020959589 scopus 로고
    • In vitro activity of HR810, a new broad-spectrum cephalosporin
    • MACHKA, K. & I. DRAVENY: In vitro activity of HR810, a new broad-spectrum cephalosporin. Eur. J. Clin. Microbiol. 2: 345-349, 1983
    • (1983) Eur. J. Clin. Microbiol. , vol.2 , pp. 345-349
    • Machka, K.1    Draveny, I.2
  • 3
    • 0021814628 scopus 로고
    • The in vitro activity and beta-lactamase stability of cefpirome (HR810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa
    • NEU, H. C.; N. X. CHIN & P. LABTHAVIKUL: The in vitro activity and beta-lactamase stability of cefpirome (HR810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa. Infection 13: 146-155, 1985
    • (1985) Infection , vol.13 , pp. 146-155
    • Neu, H.C.1    Chin, N.X.2    Labthavikul, P.3
  • 4
    • 0021970590 scopus 로고
    • Cefpirome (HR810): Lack of selection of β-lactamase overproducing variants
    • CULLMANN, W. & W. DICK: Cefpirome (HR810): Lack of selection of β-lactamase overproducing variants. J. Antibiotics 38: 912-919, 1985
    • (1985) J. Antibiotics , vol.38 , pp. 912-919
    • Cullmann, W.1    Dick, W.2
  • 5
    • 29044436622 scopus 로고
    • Chemotherapy 39(Suppl. 1): S11-S20, 1991
    • (1991) Chemotherapy , vol.39 , Issue.1 SUPPL.
  • 6
    • 29044438027 scopus 로고
    • Chemotherapy 39(Suppl. 1): S29-S39, 1991
    • (1991) Chemotherapy , vol.39 , Issue.1 SUPPL.
  • 7
    • 29044442746 scopus 로고
    • Chemotherapy 39(Suppl. 1): S46-S58, 1991
    • (1991) Chemotherapy , vol.39 , Issue.1 SUPPL.
  • 8
    • 0028280290 scopus 로고
    • Jap. J. Antibiotics 47: 143-160, 1994
    • (1994) Jap. J. Antibiotics , vol.47 , pp. 143-160
  • 9
    • 0026032219 scopus 로고
    • Chemotherapy 39: 109-130, 1991
    • (1991) Chemotherapy , vol.39 , pp. 109-130
  • 10
    • 29044438123 scopus 로고    scopus 로고
    • Japanese source
  • 11
    • 29044447856 scopus 로고    scopus 로고
    • Japanese source
  • 12
    • 29044439359 scopus 로고    scopus 로고
    • Japanese source
  • 13
    • 0001082285 scopus 로고
    • Chemotherapy 38: 103-105, 1990
    • (1990) Chemotherapy , vol.38 , pp. 103-105
  • 14
    • 0024362271 scopus 로고
    • Chemotherapy 37: 744-749, 1989
    • (1989) Chemotherapy , vol.37 , pp. 744-749
  • 15
    • 0002445522 scopus 로고
    • Chemotherapy 42: 905-914, 1994
    • (1994) Chemotherapy , vol.42 , pp. 905-914
  • 16
    • 0027744367 scopus 로고
    • Jap. J. Antibiotics 46: 939-945, 1993
    • (1993) Jap. J. Antibiotics , vol.46 , pp. 939-945
  • 17
    • 0027759682 scopus 로고
    • Jap. J. Antibiotics 46: 946-952, 1993
    • (1993) Jap. J. Antibiotics , vol.46 , pp. 946-952
  • 18
    • 29044450940 scopus 로고    scopus 로고
    • Japanese source
  • 19
    • 29044442185 scopus 로고
    • Chemotherapy 36 (Suppl. 5): S95-S116, 1988
    • (1988) Chemotherapy , vol.36 , Issue.5 SUPPL.
  • 20
    • 0025663686 scopus 로고
    • Chemotherapy 38: 1077-1082, 1990
    • (1990) Chemotherapy , vol.38 , pp. 1077-1082
  • 22
    • 29044438520 scopus 로고    scopus 로고
    • Japanese source
  • 23
    • 29044440871 scopus 로고    scopus 로고
    • Japanese source


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.